Schatzman Randall C

Avg. Two Year Performance

No purchase track record
48% Avg. Sale Return
22% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return< 1%15%(5%)30%48%
Sale Success Rate8 of 1211 of 1210 of 1212 of 1212 of 12
Drugs » Biotechnology

President and CEO, Director:

Holdings: 115.17K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Executive Officer, Director:

Holdings: 12.86K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--